Topic

Julian Upton is Pharmaceutical Executive’s European and Online Editor. He can be reached at 

Articles

How the UK is making progress in this hi-tech field.

A Step Closer to 3D Printing for Personalized Medicines

Coordination of KOL engagement is all but impossible if the information an organization collects about them is fragmented. What is needed is a centralized database that captures all information about an expert from the multiple touch points across functions and geographies.

A Single Source of Truth for KOL Mapping

Meerim Almazbek is Senior Solutions Director, Community Planning & Optimization, Global Team Lead at 

Developing a diversity mindset may begin at the top levels of the organization, but building diversity into the entire drug development life cycle ensures that it is an ongoing priority and a natural requirement of engaging with external stakeholders.

Developing a “Diversity Mindset” for Change in Pharma

Amgen board member and serial CEO Fred Hassan talks about the three levers  Fortune 500 C-suites should consider as they position their firms from pilots to enterprise-wide digital transformation.

Digital Transformation: A Journey, Not Just a Destination

) and and Lavan Thasarathakumar, Thasa Consulting.

Hannah Schofield and Lavan Thasarathakumar discuss what blockchain is, how it could help improve pharmaceutical supply chains, and the COVID-19 vaccine supply chain in particular, and touches on where we are already seeing blockchain technology being used in this area.

Blockchain, COVID-19 and the Pharmaceutical Supply Chain

Amgen is collaborating on two digital health initiatives aimed at improving heart failure care and rehabilitation.

Digital Health at the Heart of the Matter

Exposing the truth behind AI myths highlighted by COVID.

Top 5 Most Perpetuated AI Myths, Debunked

Paul Riley is Medical Affairs director at Glasshouse Health, a specialist Medical Affairs consulting practice based in Alderley Park, Macclesfield, UK. 

Colin Baughman is founder and managing partner at True North Solutions Inc., a Medical Affairs Analytics & AI consulting practice based in Cambridge, Massachusetts, USA.

Jeff Catlin is co-founder and CEO of Lexalytics, and has more than 20 years of experience in the fields of search, classification and text analytics products and services. 

Treating medical affairs solely as a support function is penny-wise and pound foolish. With the advent of machine learning, the medical affairs team can innovate and perform their many functions better and more efficiently.

     Medical Affairs: Support Function or Competitive Advantage? How AI & NLP Can Ensure It is Both

In this roundtable discussion, Steve Gens, Remco Munnik and James Kelleher explore the potential and the practicalities of building future processes on a single, joined-up content platform.

Is More Fluid Data & Document Management the Answer to Life Sciences Process Transformation?

New data comparing past vs. present experience with telemedicine during the pandemic uncovers insight on how patients, doctors, and payers view the market post-COVID.

Technology